The last prostate cancer incidence estimates in Portugal showed an average increase of 1.8%/year in the period 1998–20098, which can be explained by the population aging due to a higher life expectancy9 and the higher use of PSA as a screening test10. This evidence concerns the gene KLK3 and prostate carcinoma.